製品名:3-Hydrazino-6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazine

IUPAC Name:5-hydrazinyl-3,4-diazatricyclo[9.4.0.0²,⁷]pentadeca-1(15),2,4,6,11,13-hexaene

CAS番号:802598-74-9
分子式:C13H14N4
純度:95%+
カタログ番号:CM337866
分子量:226.28

包装単位 有効在庫 価格(USD) 数量
CM337866-100mg in stock ȌƤƋ
CM337866-250mg in stock ſȱDz
CM337866-1g 1-2 Weeks ȌȌſƋ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:802598-74-9
分子式:C13H14N4
融点:-
SMILESコード:NNC1=NN=C2C(CCCC3=CC=CC=C32)=C1
密度:
カタログ番号:CM337866
分子量:226.28
沸点:
MDL番号:
保管方法:2-8ºC

Column Infos

Bemcentinib
Bemcentinib is a potentially first-in-class selective AXL inhibitor in development for STK11 mutated NSCLC and severe respiratory infections. Extensive studies confirm the ability to combine bemcentinib with immune checkpoint inhibitors, chemotherapies and targeted therapies with the goal of improving a patient’s immune response and delaying the development of chemoresistance. Bemcentinib is currently being investigated in combination with immune checkpoint inhibition and chemotherapy in first line NSCLC patients harboring mutations in the STK11 gene, a known prognostic factor of poor response to existing therapies.

Related Products